E16.4 Billable / specific Increased secretion of gastrin
ICD-10-CM E16.4 identifies “Increased secretion of gastrin” as a billable/specific code in the FY2027 U.S. classification, effective October 1, 2026 through September 30, 2027.
Chapter 4: Endocrine, nutritional and metabolic diseases
Code-level instructions
Inclusion terms3
- Hypergastrinemia
- Hyperplasia of pancreatic endocrine cells with gastrin excess
- Zollinger-Ellison syndrome
Inherited instructions
Chapters 4 · Endocrine, nutritional and metabolic diseases (E00-E89)
Excludes 11
transitory endocrine and metabolic disorders specific to newborn (P70-P74)
Note1
All neoplasms, whether functionally active or not, are classified in Chapter 2. Appropriate codes in this chapter (i.e. E05.8, E07.0, E16-E31, E34.-) may be used as additional codes to indicate either functional activity by neoplasms and ectopic endocrine tissue or hyperfunction and hypofunction of endocrine glands associated with neoplasms and other conditions classified elsewhere.
Official index references
Official index references (8)
Abnormal, abnormality, abnormalities (2)
Ellison-Zollinger syndrome (1)
- Ellison-Zollinger syndromeDisease index
Hypergastrinemia (1)
- HypergastrinemiaDisease index
Hyperplasia, hyperplastic (1)
Hypersecretion (1)
- Hypersecretion › gastrinDisease index
Increase, increased (1)
- Increase, increased › secretion › gastrinDisease index
Zollinger-Ellison syndrome (1)
- Zollinger-Ellison syndromeDisease index
References from other codes (1)
Excludes 1 · Zollinger-Ellison syndrome (E16.4)
History
Code history
No recorded change since first observation
Effective from
- First observed
Increased secretion of gastrin
Billable diagnosis code
CDC/NCHS · FY2016All editions (19)
| All editions | Effective from | Code history |
|---|---|---|
| FY2016 | 2015-10-01 | First observed |
| FY2017 | 2016-10-01 | No tabular change |
| FY2018 | 2017-10-01 | No tabular change |
| FY2019 | 2018-10-01 | No tabular change |
| FY2020 | 2019-10-01 | No tabular change |
| FY2020 · April | 2020-04-01 | No tabular change |
| FY2021 | 2020-10-01 | No tabular change |
| FY2021 · 01-01 | 2021-01-01 | No tabular change |
| FY2022 | 2021-10-01 | No tabular change |
| FY2022 · 04-01 | 2022-04-01 | No tabular change |
| FY2023 | 2022-10-01 | No tabular change |
| FY2023 · 04-01 | 2023-04-01 | No tabular change |
| FY2024 | 2023-10-01 | No tabular change |
| FY2024 · 04-01 | 2024-04-01 | No tabular change |
| FY2025 | 2024-10-01 | No tabular change |
| FY2025 · 04-01 | 2025-04-01 | No tabular change |
| FY2026 | 2025-10-01 | No tabular change |
| FY2026 · April | 2026-04-01 | No tabular change |
| FY2027 | 2026-10-01 | No tabular change |
Historical ICD-9 mappings · 2018
Historical mapping only; not an automatic code substitution.
- 251.5
This entry is a complete code in the selected edition. Reference checks do not establish clinical appropriateness or guarantee reimbursement.